Tyagarajan Seshu - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Tyagarajan Seshu's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Technology Officer), and currently has 90,865 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Tyagarajan Seshu - Insider Non-Derivative Transactions of CADL Common Stock

Tyagarajan Seshu - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Acquisition -- (Common Stock)	5353	4.67	90865
Mar 18, 2025	Sell -- (Common Stock)	31278	8.82	85512
Mar 18, 2025	M -- (Common Stock)	20000	1.29	116790
Jan 16, 2025	Sell -- (Common Stock)	14322	7.23	96790
Jan 9, 2025	Sell -- (Common Stock)	14545	8.22	111112
Nov 30, 2024	Sell -- (Common Stock)	20392	4.56	125657
Jul 18, 2024	Sell -- (Common Stock)	14851	6.47	146049
Jul 12, 2024	Sell -- (Common Stock)	13330	5.97	160900
Nov 29, 2023	F -- (Common Stock)	17328	0.9	174230
Nov 27, 2023	Acquisition -- (Common Stock)	104516	0	191558